2 projects
Contributed to MDOT (Medical Device Obligations Taskforce) covering MDR compliance, biocompatibility testing, and safety databases, and to CO-VERSATILE for rapid medical supply production.
Organization
DEMCON LIFE SCIENCES & HEALTHEINDHOVEN B.V.
Dutch engineering firm building precision instruments and testing systems for medical devices, semiconductor equipment, and health technology applications.
Engineering firmhealthNL
H2020 projects
6
As coordinator
0
Total EC funding
—
Unique partners
171
What they do
Their core work
DEMCON Life Sciences & Health Eindhoven is the life sciences and health-focused division of DEMCON, a Dutch high-tech systems engineering group. They design and build precision instruments, mechatronic systems, and testing equipment for medical devices, semiconductor manufacturing, and healthcare applications. Their H2020 involvement as a third-party contributor across six projects reflects their role as a specialized engineering subcontractor brought in for technical design and prototyping tasks. They bridge the gap between laboratory-scale research concepts and production-ready medical and industrial equipment.
Core expertise
What they specialise in
2 projects
Third-party contributor to both SeNaTe (7nm technology) and TAPES3 (3nm semiconductor pilotline), indicating sustained involvement in advanced chip manufacturing equipment.
Precision laser micromachining systemssecondary
1 project
Contributed to ADALAM, developing sensor-based adaptive laser micromachining for zero-failure manufacturing.
Clinical trial instrumentation for neurodevelopmental researchsecondary
1 project
Third-party role in AIMS-2-TRIALS, a large autism research initiative requiring specialized measurement tools for biomarkers and clinical outcomes.
Rapid manufacturing adaptation for crisis responseemerging
1 project
Contributed to CO-VERSATILE on repurposing production lines for medical supplies during the pandemic, applying digital platform and simulation tools.
Evolution & trajectory
How they've shifted over time
Early focus
Semiconductor and precision manufacturing
Recent focus
Medical devices and health technology
Their early H2020 work (2015-2018) centered on precision manufacturing and semiconductor equipment — projects like ADALAM (laser micromachining) and SeNaTe (7nm chip technology) reflect core mechatronics and instrumentation competencies. From 2018 onward, the portfolio shifted decisively toward health and medical device domains: regulatory compliance tools (MDOT), clinical trial support (AIMS-2-TRIALS), and pandemic-driven manufacturing adaptation (CO-VERSATILE). This evolution suggests the organization is applying its engineering DNA increasingly to life sciences and healthcare — consistent with its name and likely a strategic pivot.
Moving from pure industrial engineering toward regulated health-tech, with growing capability in medical device compliance and rapid production systems — likely to deepen this health-manufacturing intersection.
Collaboration profile
How they like to work
Role: third_party_expertReach: European20 countries collaborated
DEMCON LSH Eindhoven participates exclusively as a third party, meaning they are brought in by consortium partners for specific technical contributions rather than shaping project direction. With 171 unique partners across 20 countries, they operate within large, diverse consortia — typical for ECSEL and IMI-type projects. This pattern suggests they are a trusted subcontractor valued for niche engineering capabilities, and that working with them means accessing deep technical execution without the overhead of leading a partnership.
Connected to 171 unique partners across 20 countries, largely through large-scale European consortia in semiconductor (ECSEL) and health (IMI) programs. Their network is broad but indirect — built through the parent organizations that bring them in as third parties rather than through direct consortium membership.
Why partner with them
What sets them apart
Their distinctive value lies in combining precision engineering and mechatronics expertise with deep understanding of medical device regulations and life sciences requirements. Few organizations can credibly contribute to both 3nm semiconductor pilotlines and clinical trial instrumentation for autism research. For consortium builders, they offer a rare profile: a private engineering firm that can translate research concepts into physical, testable prototypes across both health-tech and advanced manufacturing domains.
Notable projects
Highlights from their portfolio
- AIMS-2-TRIALSOne of the largest autism research initiatives in Europe (running 2018-2026), where DEMCON's involvement signals capability in sensitive clinical instrumentation and biomarker measurement.
- MDOTDirectly addresses the EU Medical Device Regulation transition — a strategically important project for any organization working in health technology compliance and safety testing.
- TAPES3Contributing to the 3nm semiconductor technology pilotline places them at the frontier of chip manufacturing equipment development in Europe.
Cross-sector capabilities
Semiconductor manufacturing equipmentPrecision industrial manufacturingDigital platforms for regulatory complianceCrisis-response production systems
More in Health & Biomedical
See all Health & Biomedical organizations →KOBENHAVNS UNIVERSITET
Denmark's largest research university, excelling in genomics, CRISPR, microbiome science, ancient DNA, and climate research across 696 H2020 projects.
Open →
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France's national biomedical research agency — 400+ H2020 projects spanning neuroscience, infectious disease, cancer, and omics-driven diagnostics.
Open →
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.
Open →